SciClone’s biggest investor wants to take over board(0)
SciClone Pharmaceuticals was told by its largest investor Friday that it intends to nominate four candidates to SciClone’s seven-person board at its next annual meeting.
The request was made by an entity controlled by the Italian pharmaceutical group, Sigma-Tau
Finanziaria, which beneficially owns 21.3 percent of SciClone’s stock.
SciClone’s Chairman, Dean Woodman, said in a filing today that the company’s board would Read the rest of this entry »
Subscribe via RSS all feeds